Similar articles for PMID: 25188344

Year	Number of Results
1914	1
1972	1
1975	1
1977	1
1986	1
1990	1
1991	2
1992	1
1993	3
1996	5
1998	1
2001	1
2002	2
2003	1
2004	4
2005	5
2006	6
2007	4
2008	3
2009	6
2010	4
2011	2
2012	2
2013	6
2014	20
2015	16
2016	5
2017	8
2018	7
2019	1
2020	3
2021	2
2022	2

1

Meeting report-workshop on spike characterizations and virus removal by filtration: trends and new developments.

Willkommen H, Blümel J, Brorson K, Chen D, Chen Q, Gröner A, Hubbard BR, Kreil TR, Ruffing M, Ruiz S, Scott D, Silvester G. Willkommen H, et al. PDA J Pharm Sci Technol. 2014 May-Jun;68(3):215-20. doi: 10.5731/pdajpst.2014.00981. PDA J Pharm Sci Technol. 2014. PMID: 25188344

2

Meeting Report: 2013 PDA Virus & TSE Safety Forum.

Willkommen H, Blümel J, Brorson K, Chen D, Chen Q, Gröner A, Hubbard BR, Kreil TR, Ruffing M, Ruiz S, Scott D, Silvester G. Willkommen H, et al. PDA J Pharm Sci Technol. 2014 May-Jun;68(3):193-214. doi: 10.5731/pdajpst.2014.00980. PDA J Pharm Sci Technol. 2014. PMID: 25188343

3

Summary of the advanced virus detection technologies users group efforts-2013.

Duncan P. Duncan P. PDA J Pharm Sci Technol. 2014 Nov-Dec;68(6):548-51. doi: 10.5731/pdajpst.2014.01018. PDA J Pharm Sci Technol. 2014. PMID: 25475627

4

Meeting report--workshop on virus removal by filtration: trends and new developments.

Willkommen H, Blümel J, Brorson K, Chen D, Chen Q, Gröner A, Kreil TR, Robertson JS, Ruffing M, Ruiz S. Willkommen H, et al. PDA J Pharm Sci Technol. 2013 Mar-Apr;67(2):98-104. doi: 10.5731/pdajpst.2013.00907. PDA J Pharm Sci Technol. 2013. PMID: 23569071

5

Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.

Gefroh E, Dehghani H, McClure M, Connell-Crowley L, Vedantham G. Gefroh E, et al. PDA J Pharm Sci Technol. 2014 May-Jun;68(3):297-311. doi: 10.5731/pdajpst.2014.00978. PDA J Pharm Sci Technol. 2014. PMID: 25188350 Review.

6

Meeting Report: PDA Virus and TSE Safety Forum.

Willkommen H, Blümel J, Brorson K, Chen D, Chen Q, Gröner A, Kreil TR, Robertson JS, Ruffing M, Ruiz S. Willkommen H, et al. PDA J Pharm Sci Technol. 2013 Mar-Apr;67(2):81-97. doi: 10.5731/pdajpst.2013.00906. PDA J Pharm Sci Technol. 2013. PMID: 23569070 Review.

7

Evaluation of anti-viral filters.

Hughes B, Bradburne A, Sheppard A, Young D. Hughes B, et al. Dev Biol Stand. 1996;88:91-8. Dev Biol Stand. 1996. PMID: 9119168 Review.

8

RUNspike, a complementary virus filter spiking method: a solution to the problem of reduced throughput due to the addition of the virus spike.

Parrella J, Wu Y, Kahn DW, Genest P. Parrella J, et al. PDA J Pharm Sci Technol. 2009 Nov-Dec;63(6):547-58. PDA J Pharm Sci Technol. 2009. PMID: 20169861

9

Need for new technologies for detection of adventitious agents in vaccines and other biological products.

Mallet L, Gisonni-Lex L. Mallet L, et al. PDA J Pharm Sci Technol. 2014 Nov-Dec;68(6):556-62. doi: 10.5731/pdajpst.2014.01012. PDA J Pharm Sci Technol. 2014. PMID: 25475629 Review.

10

Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.

De Vilmorin P, Slocum A, Jaber T, Schaefer O, Ruppach H, Genest P. De Vilmorin P, et al. PDA J Pharm Sci Technol. 2015 May-Jun;69(3):440-9. doi: 10.5731/pdajpst.2015.01054. PDA J Pharm Sci Technol. 2015. PMID: 26048749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed